In recent years Labcorp and Quest Diagnostics went on buying sprees, acquiring laboratory outreach businesses from major health systems. They argue that they can run these operations more efficiently, while the sellers get much-needed cash infusions. (See “Hospital Lab Outreach: Still a Valuable Asset,” Sept. 23, 2024.) But these deals could prove to be misguided […]
To access this post, you must purchase The Dark Report.